SÖZ
ALTI
NEWS
Home
The day in news
This week
Archive
Crisis
About
EN
AZ
sözaltı
news
Finance
Finance
EN
AZ
Jim Cramer Weighs Amgen (AMGN) After Novartis Trial Failure
finance.yahoo.com
12.09.2026 12:48
28 views
Copy link
Save
Pick
Edit
Copy link
WhatsApp
Telegram
X
Reddit
Facebook
LinkedIn
Email
More
Image
Share image
Save
Copy link
Similar stories
2 outlets
See how this story developed, hour by hour
Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%
finance.yahoo.com
08.09.2026
Why Novartis’ Drug Trial Results Are Blowing Up Amgen Stock
barrons.com
08.09.2026
Related stories
Temu’s UK sales more than double to $171mn
ft.com · 03.10
I made $500,000 from a stock sale in my IRA. Could this change my retirement?
marketwatch.com · 03.10
The U.S. jobs market just took a turn for the worse. Or did it?
marketwatch.com · 03.10
The next big AI battle is all about cuteness
marketwatch.com · 03.10
I bought a $126 concert ticket for my sister and now she can’t go. Will I be able to make a profit selling the ticket?
marketwatch.com · 03.10
As Treasury yields touch generational highs, investors brace for the market fallout
marketwatch.com · 03.10
← Previous
Jim Cramer Discussed The Contradictions Surrounding NVIDIA Corporation (NASDAQ:NVDA)’s Shares
Next →
Jim Cramer Notes lululemon (LULU) is “Executing Really Poorly”